Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Glucose and Masoprocol

supplement:

Glucose

supplement:

Masoprocol

Research Papers that Mention the Interaction

In the HFrD treatment group, NDGA administration by oral gavage decreased plasma levels of TG, glucose , FFA, and insulin, increased hepatic mitochondrial fatty acid oxidation and attenuated hepatic TG accumulation.
PloS one  •  2015  |  View Paper
While the effects of AA were insensitive to cyclooxygenase inhibition, the lipoxygenase inhibitor, nordihydroguaiaretic acid , substantially blocked the AA effect on basal glucose uptake.
The Journal of Biological Chemistry  •  2001  |  View Paper
This effect, like that of glucose , was blocked by nordihydroguaiaretic acid , a selective inhibitor of the lipooxygenase metabolic pathway, but not by inhibitors of the cyclooxygenase or cytochrome P450-monooxygenase pathways.
The Journal of biological chemistry  •  1999  |  View Paper
The lipoxygenase inhibitors BW755C and nordihydroguaiaretic acid inhibited [3H]InsP production in response to glucose , carbamylcholine, and fatty acids.
Molecular pharmacology  •  1990  |  View Paper
NDGA given alone in the presence of stimulatory concentrations of glucose suppressed the normal eight-fold rise in insulin secretion, but caused a marked enhancement in glucagon secretion that could be overcome by simultaneous inclusion of flurbiprofen.
Metabolism: clinical and experimental  •  1984  |  View Paper
Dietary administration of NDGA decreased plasma levels of TG, glucose , and insulin, and attenuated hepatic TG accumulation.
Nutrition & Metabolism  •  2016  |  View Paper
In the case of NDGA , however, the rate of fading due to dextrose is substantially reduced.
Journal of the American Pharmaceutical Association. American Pharmaceutical Association  •  1958  |  View Paper